Pepstatin A is an orally active inhibitor of aspartic proteases, which is produced by actinomycetes.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
Pepstatin A is an orally active inhibitor of aspartic proteases, which is produced by actinomycetes. It exhibits inhibitory activity with IC50 values of 4.5 nM, 6.2 nM, 150 nM, 290 nM, 520 nM, and 260 nM against hemoglobin-pepsin, hemoglobin-proctase, casein-pepsin, casein-proctase, casein-acid protease, and hemoglobin-acid protease, respectively. Additionally, pepstatin has been found to inhibit HIV protease [1-3].
Pepstatin A(0-120 μM) suppressed receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation[4]. Pepstatin A(0.1-0.3 μM) caused a reproducible, concentration-related increase in the extracellular acidification rate in two microglial cell lines, Ra2 and 6-3[5]. Pepstatin A significantly hindered influenza virus replication, probably by modulating host cell autophagic/apoptotic responses[6].
Pepstatin (0.5-50 mg/kg; p.o.) suppresses stomach ulceration of the pylorus in ligated Shay rats[1].
胃抑素Pepstatin A是由放线菌类产生的一种特异性的、具有口服活性的天冬氨酸蛋白酶 (aspartic proteases) 抑制剂,能够抑制 hemoglobin-pepsin、hemoglobin-proctase、casein-pepsin、casein-proctase、casein-acid protease 和 hemoglobin-acid protease 的活性,IC50 值分别为 4.5 nM、6.2 nM、150 nM、290 nM、520 nM 和 260 nM;Pepstatin A可抑制 HIV protease 的活性[1-3].
Pepstatin A (0-120 μM) 抑制了受体活化因子NF-κB配体(RANKL)-诱导的破骨细胞分化[4]。Pepstatin A (0.1-0.3 μM) 可以在两个微胶质细胞系Ra2和6-3中引起浓度相关的可重复的细胞外酸化率增加[5]。Pepstatin A 显著阻碍了流感病毒的复制,可能是通过调节宿主细胞自噬/凋亡反应发挥作用[6]。
Pepstatin A (0.5-50 mg/kg; p.o.)对结扎的谢氏大鼠幽门溃疡有抑制作用[1]。
参考文献:
[1]. Yoshida H, Okamoto K, et,al. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. J Biochem. 2006 Mar;139(3):583-90. doi: 10.1093/jb/mvj066. PMID: 16567424.
[2]. Seelmeier S, Schmidt H, et,al. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6. doi: 10.1073/pnas.85.18.6612. PMID: 3045820; PMCID: PMC282027.
[3]. Seelmeier S, Schmidt H, et,al. Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6. doi: 10.1073/pnas.85.18.6612. PMID: 3045820; PMCID: PMC282027.
[4]. Yoshida H, Okamoto K, et,al.Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. J Biochem. 2006 Mar;139(3):583-90. doi: 10.1093/jb/mvj066. PMID: 16567424.
[5]. Okada M, Irie S, S et,al. Pepstatin A induces extracellular acidification distinct from aspartic protease inhibition in microglial cell lines. Glia. 2003 Aug;43(2):167-74. doi: 10.1002/glia.10237. PMID: 12838508.
[6]. Matarrese P, Nencioni L, et,al. Pepstatin A alters host cell autophagic machinery and leads to a decrease in influenza A virus production. J Cell Physiol. 2011 Dec;226(12):3368-77. doi: 10.1002/jcp.22696. PMID: 21344392.
Cell experiment [1]: | |
Cell lines |
Osteoclasts |
Preparation Method |
Pepstatin A was added at 15-120 μM to the growth medium. |
Reaction Conditions |
0-120 μM |
Applications |
Pepstatin A suppressed the formation of TRAP-positive multinuclear cells in a dose-dependent manner. |
Animal experiment [2]: | |
Animal models |
Ligated Shay rats |
Dosage form |
0.5-50 mg/kg, p.o. |
Applications |
After using Pepstatin A, free sialic acid and bound sialic acid were decreased in the gastric juice of the Shay rats. |
参考文献: [1]. Yoshida H, Okamoto K, et,al. Pepstatin A, an aspartic proteinase inhibitor, suppresses RANKL-induced osteoclast differentiation. J Biochem. 2006 Mar;139(3):583-90. doi: 10.1093/jb/mvj066. PMID: 16567424. |
LX1606 Hippurate (Telotristat etiprate)
¥580.00 ¥725.00
没有评价数据